T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Pentair
PNR
$10.5B
| $17.9M | ﹤0.01% |
246,240
-4,496
| -2% | -$335K |
|
1327
Organon & Co
OGN
$3.6B
| $17.8M | ﹤0.01% |
543,576
-220,665
| -29% | -$7.06M |
|
1328
Q32 Bio
QTTB
$447M
| $17.8M | ﹤0.01% |
125,814
| – | – |
|
1329
Essential Utilities
WTRG
$11.4B
| $17.7M | ﹤0.01% |
384,869
+4,420
| +1% | +$214K |
|
1330
Cleveland-Cliffs
CLF
$6.82B
| $17.5M | ﹤0.01% |
881,659
+658,400
| +295% | +$15M |
|
1331
First American
FAF
$7.51B
| $17.4M | ﹤0.01% |
259,907
-29,883
| -10% | -$2M |
|
1332
Ormat Technologies
ORA
$7.05B
| $17.3M | ﹤0.01% |
260,219
-182,323
| -41% | -$12.6M |
|
|
AGFS
1333
DELISTED
AgroFresh Solutions Inc
AGFS
| $17.3M | ﹤0.01% |
8,022,113
-38,217
| -0.5% | -$77.2K |
|
1334
iShares Core S&P 500 ETF
IVV
$908B
| $16.8M | ﹤0.01% |
38,915
+424
| +1% | +$188K |
|
1335
BorgWarner
BWA
$13.8B
| $16.7M | ﹤0.01% |
438,498
-6,206
| -1% | -$247K |
|
1336
Douglas Dynamics
PLOW
$969M
| $16.6M | ﹤0.01% |
458,586
-245,297
| -35% | -$9.46M |
|
|
PRDS
1337
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $16.6M | ﹤0.01% |
1,666,691
-1,942
| -0.1% | -$19.3K |
|
1338
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $16.4M | ﹤0.01% |
357,100
| – | – |
|
1339
WEX
WEX
$6.7B
| $16.4M | ﹤0.01% |
92,937
-157,367
| -63% | -$28.7M |
|
1340
Natera
NTRA
$44.6B
| $16.4M | ﹤0.01% |
146,863
+8,216
| +6% | +$942K |
|
1341
TETRA Technologies
TTI
$1.25B
| $16.3M | ﹤0.01% |
5,225,733
-22,437
| -0.4% | -$72K |
|
1342
Everest Group
EG
$14.2B
| $16.1M | ﹤0.01% |
64,284
-1,298
| -2% | -$333K |
|
|
TVRD
1343
Tvardi Therapeutics
TVRD
$23.5M
| $16M | ﹤0.01% |
28,842
-255
| -0.9% | -$128K |
|
1344
Norwegian Cruise Line
NCLH
$8.76B
| $16M | ﹤0.01% |
600,175
+15,795
| +3% | +$402K |
|
|
DS
1345
DELISTED
Drive Shack Inc.
DS
| $15.7M | ﹤0.01% |
5,595,991
-62,134
| -1% | -$167K |
|
1346
Restaurant Brands International
QSR
$26.9B
| $15.7M | ﹤0.01% |
256,462
+109,100
| +74% | +$6.99M |
|
1347
NRG Energy
NRG
$26B
| $15.7M | ﹤0.01% |
383,413
-6,794
| -2% | -$289K |
|
|
VSXY
1348
Victoria's Secret
VSXY
$7.12B
| $15.6M | ﹤0.01% |
+282,955
| New | +$17.2M |
|
1349
Zions Bancorporation
ZION
$10.5B
| $15.6M | ﹤0.01% |
251,616
-4,898
| -2% | -$269K |
|
1350
Privia Health
PRVA
$2.81B
| $15.3M | ﹤0.01% |
648,493
-2,158,846
| -77% | -$75.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.